Kupando raises €10M more to take its immunity drug into the clinic
Kupando has raised an additional €10M in Series A financing, bringing its total to €23M, to fund Phase 1b trials of KUP101.
No discussion yet. Be the first to share your thoughts!
Kupando has raised an additional €10M in Series A financing, bringing its total to €23M, to fund Phase 1b trials of KUP101.
No discussion yet. Be the first to share your thoughts!